Luspatercept for the Treatment of Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT)

NCT07362095 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Acute Leukemia

Interventions

DRUG: Luspatercept

Sponsor

Zhujiang Hospital